50 related articles for article (PubMed ID: 24666252)
1. Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis.
Dulphy N; Henry G; Hemon P; Khaznadar Z; Dombret H; Boissel N; Bensussan A; Toubert A
Br J Haematol; 2014 Jun; 165(5):722-5. PubMed ID: 24666252
[No Abstract] [Full Text] [Related]
2. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
[TBL] [Abstract][Full Text] [Related]
4. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
[TBL] [Abstract][Full Text] [Related]
5. High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.
Aliagas E; Vidal A; Texidó L; Ponce J; Condom E; Martín-Satué M
Mediators Inflamm; 2014; 2014():509027. PubMed ID: 24707115
[TBL] [Abstract][Full Text] [Related]
6. INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults.
Talleur AC; Fabrizio VA; Aplenc R; Grupp SA; Mackall C; Majzner R; Nguyen R; Rouce R; Moskop A; McNerney KO
Transplant Cell Ther; 2024 Jun; 30(6):565-579. PubMed ID: 38588880
[TBL] [Abstract][Full Text] [Related]
7. Metabolic instruction of the graft-versus-leukemia immunity.
Burk AC; Apostolova P
Front Immunol; 2024; 15():1347492. PubMed ID: 38500877
[TBL] [Abstract][Full Text] [Related]
8. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T; Velázquez GF; Schmid C
Mol Cancer; 2023 Nov; 22(1):180. PubMed ID: 37951964
[TBL] [Abstract][Full Text] [Related]
9. The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.
Jiang X; Wu X; Xiao Y; Wang P; Zheng J; Wu X; Jin Z
Front Immunol; 2023; 14():1110325. PubMed ID: 36776866
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification.
Brum da Silva Nunes V; Kehl Dias C; Nathali Scholl J; Nedel Sant'Ana A; de Fraga Dias A; Granero Farias M; Alegretti AP; Sosnoski M; Esteves Daudt L; Bohns Michalowski M; Oliveira Battastini AM; Paz AA; Figueiró F
Discov Oncol; 2022 Dec; 13(1):143. PubMed ID: 36581667
[TBL] [Abstract][Full Text] [Related]
11. A novel immune prognostic model of non-M3 acute myeloid leukemia.
Ding H; Feng Y; Xu J; Lin Z; Huang J; Wang F; Luo H; Gao Y; Zhai X; Wang X; Zhang L; Niu T; Zheng Y
Am J Transl Res; 2022; 14(8):5308-5325. PubMed ID: 36105048
[TBL] [Abstract][Full Text] [Related]
12. Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives.
Leotta S; Condorelli A; Sciortino R; Milone GA; Bellofiore C; Garibaldi B; Schininà G; Spadaro A; Cupri A; Milone G
J Clin Med; 2022 Jan; 11(1):. PubMed ID: 35011994
[TBL] [Abstract][Full Text] [Related]
13. Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.
Kunadt D; Stölzel F
Cancer Manag Res; 2021; 13():7411-7427. PubMed ID: 34594134
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Giuffrida L; Sek K; Henderson MA; Lai J; Chen AXY; Meyran D; Todd KL; Petley EV; Mardiana S; Mølck C; Stewart GD; Solomon BJ; Parish IA; Neeson PJ; Harrison SJ; Kats LM; House IG; Darcy PK; Beavis PA
Nat Commun; 2021 May; 12(1):3236. PubMed ID: 34050151
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Adenine Nucleotides and Adenosine Modulate the Growth and Survival of THP-1 Leukemia Cells.
Puchałowicz K; Tarnowski M; Tkacz M; Chlubek D; Kłos P; Dziedziejko V
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580317
[TBL] [Abstract][Full Text] [Related]
16. CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions.
Mardiana S; Gill S
Front Oncol; 2020; 10():697. PubMed ID: 32435621
[TBL] [Abstract][Full Text] [Related]
17. The TGF-b/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells.
Gerner MC; Ziegler LS; Schmidt RLJ; Krenn M; Zimprich F; Uyanik-Ünal K; Konstantopoulou V; Derdak S; Del Favero G; Schwarzinger I; Boztug K; Schmetterer KG
FASEB J; 2020 Jun; 34(6):8367-8384. PubMed ID: 32319705
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract][Full Text] [Related]
19. Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line.
Willig JB; Vianna DRB; Beckenkamp A; Beckenkamp LR; Sévigny J; Wink MR; Buffon A; Pilger DA
Purinergic Signal; 2020 Mar; 16(1):29-40. PubMed ID: 31955347
[TBL] [Abstract][Full Text] [Related]
20. Immune Escape after Hematopoietic Stem Cell Transplantation (HSCT): From Mechanisms to Novel Therapies.
Bernasconi P; Borsani O
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31881776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
